
Australia to continue AstraZeneca vaccination despite blood clotting case
The Peninsula
MELBOURNE: Australia will continue its inoculation programme with AstraZeneca PLC, health officials said on Saturday, after a blood clotting case raised concern about the safety of the vaccine.
A 44-year-old man was admitted to a Melbourne hospital with clotting, days after receiving the AstraZeneca vaccine, suffering serious thrombosis, a condition that prevents normal blood flow though the circulatory system. The Therapeutic Goods Administration (TGA) regulator and a panel, the Australian Technical Advisory Group on Immunisation (ATAGI), met late Friday and early Saturday to discuss further advice on the AstraZeneca vaccine.More Related News

Qatar announces gradual return to in-person learning after Eid; full school attendance from March 29
Doha, Qatar: The Ministry of Education and Higher Education has announced the gradual resumption of in person learning across educational institutions...

Qatar announces gradual return to in-person learning after Eid; full school attendance from March 29
Doha, Qatar: The Ministry of Education and Higher Education has announced the gradual resumption of in person learning across educational institutions...











